Natural Capsules Limited Announces COO Retirement and Rights Issue for Material Subsidiary
Natural Capsules Limited has announced two significant developments. First, the company's Chief Operating Officer, Mr. MVN Kutty, will retire due to superannuation, effective September 30, 2025. Second, the company's material subsidiary, Natural Biogenex Private Limited, has approved a rights issue of 11,11,200 equity shares at ₹10 per share, totaling ₹1,11,12,000.

*this image is generated using AI for illustrative purposes only.
Natural Capsules Limited , a prominent player in the pharmaceutical industry, has made two significant announcements that could impact its operational structure and financial position.
Retirement of Chief Operating Officer
Natural Capsules Limited has disclosed the retirement of Mr. MVN Kutty, the company's Chief Operating Officer (COO). According to the company's filing with the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), Mr. Kutty's retirement is due to superannuation and will be effective from the close of business hours on September 30, 2025.
The retirement announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided the following details in its regulatory filing:
Particulars | Details |
---|---|
Name | Mr. MVN Kutty |
Designation | Chief Operating Officer |
Reason for change | Retirement on attaining superannuation |
Date of cessation | Close of business hours on September 30, 2025 |
Rights Issue for Material Subsidiary
In a separate announcement made on the same day, Natural Capsules Limited informed the stock exchanges about a significant development concerning its material subsidiary, Natural Biogenex Private Limited. The Board of Directors of Natural Biogenex Private Limited has approved a rights issue in their meeting held on September 30, 2025.
The key details of the rights issue are as follows:
Particulars | Details |
---|---|
Number of Equity Shares | 11,11,200 |
Face Value | ₹10.00 each |
Issue Price | At par (₹10.00 per share) |
Total Issue Size | ₹1,11,12,000.00 |
This rights issue is expected to infuse additional capital into Natural Biogenex Private Limited, potentially strengthening its financial position and supporting its growth initiatives.
Both announcements were made by Pranjal Deshmukh, the Company Secretary & Compliance Officer of Natural Capsules Limited, in accordance with regulatory requirements. These developments may have implications for the company's operational strategy and financial outlook in the coming months.
Investors and stakeholders of Natural Capsules Limited are advised to take note of these announcements and assess their potential impact on the company's future performance.
Historical Stock Returns for Natural Capsules
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.75% | +25.61% | +38.47% | +43.41% | +9.02% | +9.02% |